Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psoriasis-Type Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01212757
What this trial is testing

PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Who this might be right for
Psoriatic Arthritis
Amgen 488
Testing effectiveness (Phase 2)Study completedNCT00770965
What this trial is testing

Phase II Efficacy Study Looking at a Single-dose of One of Three Dose Levels of AIN457 in Patients With Chronic Plaque-type Psoriasis

Who this might be right for
Chronic Plaque Psoriasis
Novartis Pharmaceuticals 80
Testing effectiveness (Phase 2)WithdrawnNCT02011269
What this trial is testing

TSO for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Coronado Biosciences, Inc.
Not applicableUnknownNCT01339741
What this trial is testing

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Who this might be right for
Psoriasis VulgarisVitamin D Deficiency
Chulalongkorn University 30
Large-scale testing (Phase 3)Study completedNCT01309737
What this trial is testing

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 960
Not applicableStudy completedNCT01687582
What this trial is testing

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Who this might be right for
Type 2 DiabetesPsoriasis
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 10
Not applicableStudy completedNCT01320293
What this trial is testing

Cardiovascular Effects in Psoriasis Patients Treated With Adalimumab.

Who this might be right for
Psoriasis
University of North Carolina, Chapel Hill 18
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT02872285
What this trial is testing

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Moderate Chronic Plaque-type Psoriasis

Who this might be right for
Psoriasis
Lycera Corp. 33
Not applicableStudy completedNCT00824889
What this trial is testing

Exploratory Study of Natural Killer Cells in Human Skin

Who this might be right for
Atopic DermatitisContact DermatitisPsoriasis+3 more
Assistance Publique Hopitaux De Marseille 28
Post-approval studies (Phase 4)Study completedNCT01012713
What this trial is testing

Safety and Efficacy Study of Combination Treatment With Excimer Laser, Clobex Spray, and Vectical Ointment in the Treatment of Psoriasis

Who this might be right for
Chronic Stable Plaque Psoriasis
University of California, San Francisco 30
Large-scale testing (Phase 3)Study completedNCT02362789
What this trial is testing

Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 132
Testing effectiveness (Phase 2)Study completedNCT00763503
What this trial is testing

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis

Who this might be right for
Plaque-type Psoriasis
Galderma R&D 26
Large-scale testing (Phase 3)WithdrawnNCT01121081
What this trial is testing

The Effect of Algae Dunaliella Bardawil on Psoriasis (2)

Who this might be right for
Psoriasis
Sheba Medical Center
Testing effectiveness (Phase 2)WithdrawnNCT02472717
What this trial is testing

Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study

Who this might be right for
Psoriatic ArthritisPsoriasisImpaired Glucose Tolerance+1 more
University Health Network, Toronto
Testing effectiveness (Phase 2)Study completedNCT02622386
What this trial is testing

The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of Michigan 23
Not applicableStudy completedNCT01081730
What this trial is testing

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

Who this might be right for
Psoriasis
Janssen Biotech, Inc. 2,040
Not applicableEnrolling By InvitationNCT06583395
What this trial is testing

Quest to Analyze One Thousand Humans Meditating

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)Angina, StableAnxiety+52 more
Tobias Moeller-Bertram 3,000
Not applicableLooking for participantsNCT07545902
What this trial is testing

Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis

Who this might be right for
Plaque Type PsorisisNon-pustular Palmoplantar Psoriasis
ICIM International S.r.l. 35
Large-scale testing (Phase 3)Study completedNCT01690299
What this trial is testing

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

Who this might be right for
PsoriasisPsoriatic Arthritis
Amgen 250
Next Page